[1]
M. Lustig, “Direct-to-Consumer Prescription Drug Advertising in the United States: A Narrative Review of Clinical, Public-Health, Ethical, and Economic Implications”, jmhs, vol. 7, no. 7, pp. 37–41, May 2026, doi: 10.32996/jmhs.2027.7.5.